Stay updated on AstraZeneca PLC ADR Press Releases
Sign up to get notified when there's something new on the AstraZeneca PLC ADR Press Releases page.
Latest updates to the AstraZeneca PLC ADR Press Releases page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecent updates highlight Lynparza's significant survival benefits in early breast cancer and the breakthrough therapy designation for Datopotamab deruxtecan in advanced lung cancer, while previous submissions and trial results for Tezspire have been removed.SummaryDifference69%
- Check15 days agoChange DetectedAstraZeneca has received Priority Review for Imfinzi in the US for muscle-invasive bladder cancer and has approved it as the first immunotherapy for limited-stage small cell lung cancer, while Iskra Reic has been appointed as Executive Vice President, International.SummaryDifference66%
- Check22 days agoChange DetectedThe CAPItello-281 Phase III trial reported that the Truqap combination significantly improved radiographic progression-free survival in PTEN-deficient metastatic hormone-sensitive prostate cancer.SummaryDifference10%
- Check29 days agoChange DetectedTagrisso has been recommended for approval in the EU for patients with unresectable EGFR-mutated lung cancer, highlighting a significant advancement in treatment options.SummaryDifference59%
- Check36 days agoChange DetectedAstraZeneca has made significant investments in R&D and manufacturing in the US, while also submitting a new BLA for Datopotamab deruxtecan for advanced lung cancer, and reporting positive results for Koselugo in treating neurofibromatosis type 1.SummaryDifference33%
- Check43 days agoChange DetectedThe website has added a comprehensive search menu and new sections highlighting AstraZeneca's R&D approach, therapy areas, sustainability efforts, and recent clinical trial results, while removing specific details about recent drug approvals and trial outcomes.SummaryDifference100%
Stay in the know with updates to AstraZeneca PLC ADR Press Releases
Enter your email address, and we'll notify you when there's something new on the AstraZeneca PLC ADR Press Releases page.